ImCure Therapeutics

ImCure Therapeutics was a private biotechnology company focused on developing small-molecule therapeutics, particularly water-soluble phenazine compounds. Publicly available company-profile and patent sources indicate that its programs were aimed at autoimmune and inflammatory diseases such as arthritis and rheumatoid arthritis, with broader references to cardiovascular disease, cancer, and tuberculosis. The company appears to have been founded in 2004 and was previously known as JJ Pharma. It raised early-stage venture financing in 2007 and 2009, but later appears to have gone out of business. The available evidence does not show an approved product or an active late-stage clinical pipeline.